EssilorLuxottica (ESLOY) has a profit margin of 8.64%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
EssilorLuxottica (ESLOY) currently reports a profit margin of 8.64% as of June 2026. That compares with 9.16% in the prior-year period — down 5.7% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore EssilorLuxottica's profit margin history and peer comparisons.
EssilorLuxottica's profit margin decreased from 9.16% to 8.64% — a 5.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
EssilorLuxottica's profit margin of 8.64% is lower than the Healthcare sector average of 13.89%. That is roughly 37.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but EssilorLuxottica's current 8.64% should be judged against Healthcare norms (sector average: 13.89%) and against ESLOY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 8.64%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for EssilorLuxottica, and consider following ESLOY for alerts when major investors trade the stock.